Kelly Dare Moynihan

Title: **Kelly Dare Moynihan: Innovator in Immune Modulation**

Introduction

Kelly Dare Moynihan is a prominent inventor based in San Francisco, California, known for his contributions to the field of immunology. With a focus on enhancing immune cell function, he has developed innovative solutions that hold promise for various therapeutic applications.

Latest Patents

Moynihan holds a patent for "Fusions with CD8 antigen binding molecules for modulating immune cell function." This patent outlines the development of anti-CD8 antigen binding molecules and fusion polypeptides designed to selectively modulate the function of CD8+ T cells, distinguishing them from other immune cells. The patent also includes polynucleotides encoding these molecules, along with their vectors and host cells. Furthermore, it describes methods for producing these antigen binding molecules and fusion polypeptides, as well as pharmaceutical compositions that incorporate them.

Career Highlights

Currently, Kelly Dare Moynihan is affiliated with Asher Biotherapeutics, Inc., where he applies his expertise to advance biotherapeutics. His work at the company positions him at the forefront of immunotherapy research, contributing significantly to the development of new treatments.

Collaborations

During his professional journey, Moynihan has collaborated with notable colleagues, including Yik Andy Yeung and Ivana Djuretic. These collaborations highlight the innovative spirit and teamwork that drives research and development within his field.

Conclusion

In summary, Kelly Dare Moynihan exemplifies a dynamic inventor whose work in modulating immune cell function has the potential to transform therapeutic approaches. His patent not only underscores his innovative capabilities but also reflects the collaborative nature of advancements in biotherapeutics. As he continues to develop and refine his inventions, Moynihan's contributions are sure to play a pivotal role in the future of immunology.